AU2003208505A8 - Process for preparation of a pharmaceutical composition containing acid labile compounds - Google Patents

Process for preparation of a pharmaceutical composition containing acid labile compounds

Info

Publication number
AU2003208505A8
AU2003208505A8 AU2003208505A AU2003208505A AU2003208505A8 AU 2003208505 A8 AU2003208505 A8 AU 2003208505A8 AU 2003208505 A AU2003208505 A AU 2003208505A AU 2003208505 A AU2003208505 A AU 2003208505A AU 2003208505 A8 AU2003208505 A8 AU 2003208505A8
Authority
AU
Australia
Prior art keywords
preparation
pharmaceutical composition
composition containing
acid labile
containing acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003208505A
Other versions
AU2003208505A1 (en
Inventor
Bakulesh Mafatlal Khamar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAVE BRIJESH
RAMANI CHANDIR CHIMANDAS
Original Assignee
DAVE BRIJESH
RAMANI CHANDIR CHIMANDAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DAVE BRIJESH, RAMANI CHANDIR CHIMANDAS filed Critical DAVE BRIJESH
Publication of AU2003208505A8 publication Critical patent/AU2003208505A8/en
Publication of AU2003208505A1 publication Critical patent/AU2003208505A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003208505A 2002-03-08 2003-03-06 Process for preparation of a pharmaceutical composition containing acid labile compounds Abandoned AU2003208505A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN235MU2002 2002-03-08
IN235/MUM/2002 2002-03-08
PCT/IB2003/000827 WO2003077829A2 (en) 2002-03-08 2003-03-06 Process for preparation of a pharmaceutical composition containing acid labile compounds

Publications (2)

Publication Number Publication Date
AU2003208505A8 true AU2003208505A8 (en) 2003-09-29
AU2003208505A1 AU2003208505A1 (en) 2003-09-29

Family

ID=27799867

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2003209534A Abandoned AU2003209534A1 (en) 2002-03-08 2003-03-04 The method of treating tuberculosis
AU2003208505A Abandoned AU2003208505A1 (en) 2002-03-08 2003-03-06 Process for preparation of a pharmaceutical composition containing acid labile compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2003209534A Abandoned AU2003209534A1 (en) 2002-03-08 2003-03-04 The method of treating tuberculosis

Country Status (4)

Country Link
KR (1) KR20050008452A (en)
AU (2) AU2003209534A1 (en)
GB (1) GB2392839A (en)
WO (2) WO2003075825A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006111853A2 (en) * 2005-04-18 2006-10-26 Aurobindo Pharma Limited Stable solid dosage forms of acid labile drug
EP1948782B8 (en) 2005-04-25 2012-09-12 Cadila Pharmaceuticals Limited Vaccine adjuvants
ATE524972T1 (en) * 2006-11-23 2011-10-15 Cadila Pharmaceuticals Ltd POLY-TLR ANTAGONIST
WO2010122583A2 (en) 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8918206D0 (en) * 1989-08-09 1989-09-20 Nat Inst Immunology Tuberculosis vaccine
US5232706A (en) * 1990-12-31 1993-08-03 Esteve Quimica, S.A. Oral pharmaceutical preparation containing omeprazol
SE9302395D0 (en) * 1993-07-09 1993-07-09 Ab Astra NEW PHARMACEUTICAL FORMULATION
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
GB2400560A (en) * 2002-01-29 2004-10-20 Rajiv Indravadan Modi Method of providing prophylaxis for tuberculosis in hiv positive individuals

Also Published As

Publication number Publication date
WO2003075825A2 (en) 2003-09-18
GB0400094D0 (en) 2004-02-04
AU2003209534A1 (en) 2003-09-22
KR20050008452A (en) 2005-01-21
AU2003209534A8 (en) 2003-09-22
WO2003077829A2 (en) 2003-09-25
AU2003208505A1 (en) 2003-09-29
GB2392839A (en) 2004-03-17
GB2392839A8 (en) 2004-11-18
WO2003077829A3 (en) 2003-12-04
WO2003075825A3 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
HK1050357B (en) New -amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0301459A3 (en) Chemical compounds process for producing them and pharmaceutical compositions containing them
HUP0201646A3 (en) Novel alpha-amino acid derivatives, process for producing them and pharmaceutical compositions containing them
IL190218A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
HUP0204496A3 (en) Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same
HUP0303347A3 (en) Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis polymorphonucleate and mononucleate cells, process for their preparation and pharmaceutical compositions containing them
HK1086485A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
IL166269A0 (en) A pharmaceutical composition containing an activated form of diluted antibodies to ?-tnf
AP1930A (en) Alpha crystalline form of strontium ranelate, a process for its preparation and pharmaceutical compositions containing it
HK1042698B (en) New diphenylurea compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0400208A3 (en) N-formyl hydroxylamine compounds, process for their preparation and pharmaceutical compositions containing them
AU2001258677A1 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
HUP0200213A2 (en) Alkynyl containing hydroxamic acid compounds as tace inhibitors, process for their preparation and pharmaceutical compositions containing them
AU2003231920A8 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
AU2003208505A8 (en) Process for preparation of a pharmaceutical composition containing acid labile compounds
HK1049159B (en) New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them
EG24369A (en) New isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them
HK1049000B (en) New isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them
HU0105328D0 (en) Novel bicyclic amino-pirazinone compounds, a process for their preparation and pharmaceutical compositions containing them
HK1053646A1 (en) BenzoÄBÜpyranoÄ3,2-HÜacridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them
SG110170A1 (en) New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them
HK1039943A1 (en) New aryl or heteroaryl quinolylphosphonic acid compounds, a process for their preparation and pharmaceutical compositions containing them
HK1040518A1 (en) New 6-amino or 6-hydrazino-sulphonyl-3-quinolynylphosphonic acid compounds, a process for their preparation and pharmaceutical compositions containing them
HK1039619A1 (en) New-6-sulphamoyl-3-quinolylphosphonic acid compounds, a process for their preparation and pharmaceutical compositions containing them
HK1078566A1 (en) New 3-aryl-2, 5-dihydroxy-1, 4-benzoquinone compounds, a process for their preparation ahd pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase